These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 16437368
21. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Schwarz RE, Smith DD. Ann Surg Oncol; 2007 Feb; 14(2):317-28. PubMed ID: 17094022 [Abstract] [Full Text] [Related]
22. Carcinoembryonic antigen in patients with gastric carcinoma. Janssen CW, Orjasaeter H. Eur J Surg Oncol; 1986 Mar; 12(1):19-23. PubMed ID: 3956751 [Abstract] [Full Text] [Related]
23. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer. Ojima H, Araki K, Kato T, Okamura K, Manda R, Hirayama I, Hosouchi Y, Nishida Y, Kuwano H. Anticancer Res; 2006 Mar; 26(2B):1385-90. PubMed ID: 16619548 [Abstract] [Full Text] [Related]
24. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients. Kwon HC, Oh SY, Lee S, Kim SH, Han JY, Koh RY, Kim MC, Kim HJ. Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711 [Abstract] [Full Text] [Related]
25. [Multivariate prognostic analysis for patients with curative resection of gastric cardia cancer]. Zhang CH, He YL, Zhan WH, Chen CQ, Cai SR, Huang MJ. Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):483-7. PubMed ID: 17143790 [Abstract] [Full Text] [Related]
28. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? Lim S, Muhs BE, Marcus SG, Newman E, Berman RS, Hiotis SP. J Surg Oncol; 2007 Feb 01; 95(2):118-22. PubMed ID: 17262741 [Abstract] [Full Text] [Related]
30. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Ohro S, Tatebe S, Tsujitani S, Ikeguchi M. J Surg Oncol; 2007 Feb 01; 95(2):123-8. PubMed ID: 17262742 [Abstract] [Full Text] [Related]
31. Is gastrectomy mandatory for all residual or recurrent gastric cancer following endoscopic resection? A large-scale Korean multi-center study. Song KY, Hyung WJ, Kim HH, Han SU, Cho GS, Ryu SW, Lee HJ, Kim MC, Korean Laparoscopic Gastrointestinal Surgery Study (KLASS) Group. J Surg Oncol; 2008 Jul 01; 98(1):6-10. PubMed ID: 18521830 [Abstract] [Full Text] [Related]
32. [Clinicopathological analysis of synchronous liver metastasis in gastric cancer and evaluation of surgical outcomes]. Li YM, Zhan WH, Han FH, He YL, Peng JS, Cai SR, Ma JP, Zhao G. Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar 01; 9(2):127-30. PubMed ID: 16555151 [Abstract] [Full Text] [Related]
33. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer. Guo E, Chen L, Xie Q, Chen J, Tang Z, Wu Y. Ann Surg Oncol; 2007 Sep 01; 14(9):2528-34. PubMed ID: 17597347 [Abstract] [Full Text] [Related]
34. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. Saito H, Fukumoto Y, Osaki T, Yamada Y, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M. J Surg Oncol; 2008 Feb 01; 97(2):132-5. PubMed ID: 17979134 [Abstract] [Full Text] [Related]
35. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Yie SM, Lou B, Ye SR, Cao M, He X, Li P, Hu K, Rao L, Wu SM, Xiao HB, Gao E. Ann Surg Oncol; 2008 Nov 01; 15(11):3073-82. PubMed ID: 18670822 [Abstract] [Full Text] [Related]
36. Surgical results of early gastric cancer and proposing a treatment strategy. Lo SS, Wu CW, Chen JH, Li AF, Hsieh MC, Shen KH, Lin HJ, Lui WY. Ann Surg Oncol; 2007 Feb 01; 14(2):340-7. PubMed ID: 17094028 [Abstract] [Full Text] [Related]